|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-9-2
|
|
pubmed:abstractText |
To develop a novel protein-anchor technology to immobilize human interleukin-2 on tumor cells to induce antitumor immunity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1527-9995
|
|
pubmed:author |
pubmed-author:EybenEE,
pubmed-author:GaoJiminJ,
pubmed-author:GuoFangfangF,
pubmed-author:HuZhimingZ,
pubmed-author:JingYumingY,
pubmed-author:LiJinlongJ,
pubmed-author:ShiXiaojunX,
pubmed-author:SunPengyuP,
pubmed-author:TanWanlongW,
pubmed-author:ZhangXinjiX,
pubmed-author:ZhangZhehuanZ
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
722.e1-722.e6
|
|
pubmed:meshHeading |
pubmed-meshheading:21741685-Animals,
pubmed-meshheading:21741685-Cancer Vaccines,
pubmed-meshheading:21741685-Cell Line, Tumor,
pubmed-meshheading:21741685-Cytotoxicity, Immunologic,
pubmed-meshheading:21741685-Female,
pubmed-meshheading:21741685-Humans,
pubmed-meshheading:21741685-Immunotherapy,
pubmed-meshheading:21741685-Interleukin-2,
pubmed-meshheading:21741685-Lung Neoplasms,
pubmed-meshheading:21741685-Mice,
pubmed-meshheading:21741685-Mice, Inbred C57BL,
pubmed-meshheading:21741685-Recombinant Fusion Proteins,
pubmed-meshheading:21741685-Streptavidin,
pubmed-meshheading:21741685-T-Lymphocytes,
pubmed-meshheading:21741685-Urinary Bladder Neoplasms
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Novel immunotherapy for metastatic bladder cancer using vaccine of human interleukin-2 surface-modified MB 49 cells.
|
|
pubmed:affiliation |
Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
